Low storage costs (Pharmaceutical)
Last Updated by Anonymous | Update This Page Delete This Page
When storage costs are low, competitors have a lower risk of having to unload their inventory all at once. Low storage costs are a positive for Pharmaceutical. … "Low storage costs (Pharmaceutical)" has a significant impact, so an analyst should put more weight into it. This qualitative factor will lead to a decrease in costs. "Low storage costs (Pharmaceutical)" is a difficult qualitative factor to defend, so competing institutions will have an easy time overcoming it. "Low storage costs (Pharmaceutical)" will have a long-term negative impact on this entity, which subtracts from the entity's value. This statements will have a short-term negative impact on this entity, which subtracts from its value. "Low storage costs (Pharmaceutical)" is a difficult qualitative factor to overcome, so the investment will have to spend a lot of time trying to overcome this issue. |
Five Forces Analysis Survey |

Intensity of Existing Rivalry: Low storage costs (Pharmaceutical)
When storage costs are low, competitors have a lower risk of having to unload their inventory all at once. Low storage costs are a positive for Pharmaceutical.
If you believe that this point is inaccurate, please flag this page to notify administrators and moderators.